ABIVAX Société Anonyme (EPA:ABVX)
77.95
-1.00 (-1.27%)
Oct 19, 2026, 5:35 PM CET
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 1.20M EUR in the quarter ending June 30, 2026, with 9.88% growth. This brings the company's total for the last twelve months to 5.03M, down -34.88% year-over-year. In the year 2025, ABIVAX Société Anonyme had annual revenue of 4.57M, down -63.29%. That makes ABIVAX Société Anonyme the 39,802nd largest company in the world by revenue and 521st in France.
Revenue (ttm)
5.03M
Revenue Growth
-34.88%
P/S Ratio
1,455.75
Revenue / Employee
47.63K
Employees
98
Market Cap
6.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.57M | -7.88M | -63.29% |
| Dec 31, 2024 | 12.45M | 7.83M | 169.40% |
| Dec 31, 2023 | 4.62M | 38.00K | 0.83% |
| Dec 31, 2022 | 4.58M | -7.38M | -61.68% |
| Dec 31, 2021 | 11.96M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2016 | 151.00K | -77.00K | -33.77% |
| Dec 31, 2015 | 228.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 142.94M |
| Genfit | 59.49M |
| Cellectis | 55.86M |
| MedinCell | 24.28M |
| Nanobiotix | 11.51M |
| Innate Pharma | 9.81M |
| Transgene | 5.62M |
| Valerio Therapeutics Société anonyme | 5.55M |
ABIVAX Société Anonyme News
- 27 days ago - Abivax price target lowered to $118 from $140 at Wedbush - TheFly
- 27 days ago - Abivax price target lowered to $151 from $155 at Truist - TheFly
- 4 weeks ago - Abivax appoints Chris Rabbat as Chief Medical Officer - TheFly
- 4 weeks ago - Abivax Presents Business Updates and First Half 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - ABIVAX Société Anonyme Earnings release: Q2 2026 - Filings
- 4 weeks ago - ABIVAX Société Anonyme Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Will Abivax Stock (ABVX) Rise or Fall After Q2 Earnings? - TipRanks
- 5 weeks ago - Earnings To Watch: Abivax SA (XPAR:ABVX) Reports Q2 2026 Result - GuruFocus